Target intelligence / Profile preview

Human immune response modulation

Molecular classification
Other
01

Overview

Human immune response modulation refers to the therapeutic intervention aimed at altering the immune system's activity, either by enhancing or suppressing its components. It is not a single molecular target but a complex biological process involving a network of cells, signaling molecules, and receptors (National Cancer Institute, 2024). In the context of autoimmune diseases and organ transplantation, modulation typically involves immunosuppression to prevent tissue damage or rejection. Conversely, in oncology and infectious diseases, immunostimulation is employed to bolster the body's natural defenses against pathogens or tumor cells (StatPearls, 2023). Because this term describes a broad physiological outcome, it is considered a therapeutic category rather than a discrete protein or enzyme target. Drugs classified as immunomodulators achieve their effects by interacting with specific targets such as cytokines, checkpoint receptors, or intracellular signaling kinases (Nature Reviews Drug Discovery, 2020).

Other names
ImmunomodulationImmune regulationImmune system modulationImmunotherapy
02

Mechanism of action

The mechanism of action varies significantly depending on the specific molecular target involved, but generally entails the modulation of signaling pathways to either suppress or stimulate immune cell activity, cytokine release, and antibody production (StatPearls, 2023).

03

Biological functions

Immune responseInflammationHomeostasisSignal transduction
04

Disease associations

CancerAutoimmune diseaseInfectious diseaseAllergyInflammation
05

Safety considerations

Increased susceptibility to opportunistic infectionsCytokine release syndrome (CRS)Immune-related adverse events (irAEs)Potential for secondary malignanciesHypersensitivity reactions
06

Interacting drugs

Cyclosporine

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) levelsAbsolute lymphocyte count (ALC)T-cell subset counts (CD4+/CD8+ ratio)Soluble interleukin-2 receptor (sIL-2R)

Beyond the preview

Go deeper on Human immune response modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immune response modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call